34831286|t|RNF13 Dileucine Motif Variants L311S and L312P Interfere with Endosomal Localization and AP-3 Complex Association.
34831286|a|Developmental and epileptic encephalopathies (DEE) are rare and serious neurological disorders characterized by severe epilepsy with refractory seizures and a significant developmental delay. Recently, DEE73 was linked to genetic alterations of the RNF13 gene, which convert positions 311 or 312 in the RNF13 protein from leucine to serine or proline, respectively (L311S and L312P). Using a fluorescence microscopy approach to investigate the molecular and cellular mechanisms affected by RNF13 protein variants, the current study shows that wild-type RNF13 localizes extensively with endosomes and lysosomes, while L311S and L312P do not extensively colocalize with the lysosomal marker Lamp1. Our results show that RNF13 L311S and L312P proteins affect the size of endosomal vesicles along with the temporal and spatial progression of fluorescently labeled epidermal growth factor, but not transferrin, in the endolysosomal system. Furthermore, GST-pulldown and co-immunoprecipitation show that RNF13 variants disrupt association with AP-3 complex. Knockdown of AP-3 complex subunit AP3D1 alters the lysosomal localization of wild-type RNF13 and similarly affects the size of endosomal vesicles. Importantly, our study provides a first step toward understanding the cellular and molecular mechanism altered by DEE73-associated genetic variations of RNF13.
34831286	0	5	RNF13	Gene	11342
34831286	31	36	L311S	ProteinMutation	tmVar:p|SUB|L|311|S;HGVS:p.L311S;VariantGroup:0;CorrespondingGene:8943;RS#:1241556231;CorrespondingSpecies:9606
34831286	41	46	L312P	ProteinMutation	tmVar:p|SUB|L|312|P;HGVS:p.L312P;VariantGroup:2;CorrespondingGene:11342;CorrespondingSpecies:9606
34831286	115	159	Developmental and epileptic encephalopathies	Disease	MESH:C562695
34831286	161	164	DEE	Disease	MESH:C562695
34831286	187	209	neurological disorders	Disease	MESH:D009461
34831286	234	242	epilepsy	Disease	MESH:D004827
34831286	259	267	seizures	Disease	MESH:D012640
34831286	286	305	developmental delay	Disease	MESH:D002658
34831286	364	369	RNF13	Gene	11342
34831286	418	423	RNF13	Gene	11342
34831286	437	454	leucine to serine	ProteinMutation	tmVar:p|SUB|L||S;VariantGroup:1;CorrespondingGene:11342;CorrespondingSpecies:9606
34831286	481	486	L311S	ProteinMutation	tmVar:p|SUB|L|311|S;HGVS:p.L311S;VariantGroup:0;CorrespondingGene:8943;RS#:1241556231;CorrespondingSpecies:9606
34831286	491	496	L312P	ProteinMutation	tmVar:p|SUB|L|312|P;HGVS:p.L312P;VariantGroup:2;CorrespondingGene:11342;CorrespondingSpecies:9606
34831286	605	610	RNF13	Gene	11342
34831286	668	673	RNF13	Gene	11342
34831286	732	737	L311S	ProteinMutation	tmVar:p|SUB|L|311|S;HGVS:p.L311S;VariantGroup:0;CorrespondingGene:8943;RS#:1241556231;CorrespondingSpecies:9606
34831286	742	747	L312P	ProteinMutation	tmVar:p|SUB|L|312|P;HGVS:p.L312P;VariantGroup:2;CorrespondingGene:11342;CorrespondingSpecies:9606
34831286	804	809	Lamp1	Gene	3916
34831286	833	838	RNF13	Gene	11342
34831286	839	844	L311S	ProteinMutation	tmVar:p|SUB|L|311|S;HGVS:p.L311S;VariantGroup:0;CorrespondingGene:8943;RS#:1241556231;CorrespondingSpecies:9606
34831286	849	854	L312P	ProteinMutation	tmVar:p|SUB|L|312|P;HGVS:p.L312P;VariantGroup:2;CorrespondingGene:11342;CorrespondingSpecies:9606
34831286	975	998	epidermal growth factor	Gene	1950
34831286	1008	1019	transferrin	Gene	7018
34831286	1113	1118	RNF13	Gene	11342
34831286	1201	1206	AP3D1	Gene	8943
34831286	1254	1259	RNF13	Gene	11342
34831286	1467	1472	RNF13	Gene	11342
34831286	Association	MESH:C562695	11342
34831286	Positive_Correlation	MESH:C562695	RS#:1241556231;HGVS:p.L311S;CorrespondingGene:8943
34831286	Positive_Correlation	MESH:C562695	HGVS:p.L312P;CorrespondingGene:11342
34831286	Association	11342	1950
34831286	Association	11342	8943
34831286	Association	MESH:C562695	8943
34831286	Association	MESH:C562695	11342

